By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Targanta Therapeutics 

222 3rd Street
Suite 2300
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-577-9020 Fax: 617-577-9021


Key Statistics

Ownership: Private

Web Site: Targanta Therapeutics


Company News
The Medicines Company (MDCO) Completes Acquisition of Targanta Therapeutics 2/26/2009 10:51:22 AM
The Medicines Company (MDCO) Announces Completion of Tender Offer for Shares of Targanta Therapeutics 2/25/2009 10:47:14 AM
Targanta Therapeutics Enters into Memorandum of Understanding to Resolve Shareholder Lawsuit 2/20/2009 9:18:48 AM
The Medicines Company (MDCO) Commences Tender Offer for All Outstanding Shares of Targanta Therapeutics 1/27/2009 11:24:36 AM
The Medicines Company (MDCO) to Buy Targanta Therapeutics for $42 Million 1/13/2009 6:52:34 AM
Targanta Therapeutics Announces Corporate Restructuring, Reduces 75% of Workforce 12/19/2008 7:21:25 AM
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum 12/2/2008 12:29:28 PM
Targanta Therapeutics Announces Posting of Briefing Documents for Review of FDA Anti-Infective Drugs Advisory Committee Meeting for Oritavancin 11/17/2008 12:03:21 PM
Shares of Targanta Therapeutics Surge on Positive FDA Review 11/17/2008 11:11:43 AM
Targanta Therapeutics Reports Third-Quarter 2008 Financial Results 11/12/2008 10:49:04 AM